Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-03
2008-12-02
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S521000
Reexamination Certificate
active
07459448
ABSTRACT:
The present invention provides novel compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
REFERENCES:
patent: 5854236 (1998-12-01), Albright et al.
patent: 6686352 (2004-02-01), Masciadri et al.
patent: 2003/0083327 (2003-05-01), Davies et al.
patent: 2003/0181439 (2003-09-01), Meijer et al.
patent: WO 02/094834 (2002-11-01), None
patent: WO 2004/076424 (2004-09-01), None
patent: WO 2005/037843 (2005-04-01), None
patent: WO 2005/111039 (2005-11-01), None
Chetoni, Fabio, et al., “Synthesis of Novel 1-Aryl[1]benzoxepino[5,4-c]pyrazole and [1]Benzoxepino[5,4-d]pyrimidine Derivatives,”Journal of Heterocyclic Chemistry, vol. 30 (Dec. 1993) pp. 1653-1658.
Chen, Wen-Yean, et al., “Synthesis of 7-Phenylpyrimido[5,4-d][1]benzazepin-2-ones (1),”Journal of Heterocyclic Chemistry, vol. 20 (May-Jun. 1983) pp. 663-666.
Kunick, Conrad, et al., “Evaluation and Comparison of 3D-QSAR CoMSIA Models for CDK1, CDK5, and GSK-3 Inhibition by Paullones,”Journal of Medicinal Chemistry, vol. 47, No. 1 (2004) pp. 22-36.
Link, Andreas, et al., “d-Fused [1]Benzazepines with Selective in Vitro Antitumor Activity: Synthesis and Structure-Activity Relationships,”Journal of Medicinal Chemistry. vol. 41, No. 8 (1998) pp. 1299-1305.
Leost, Maryse, et al., “Paullones Are Potent Inhibitors of Glycogen Synthase Kinase-3β and Cyclin-Dependent Kinase 5/p25,”Journal of Biochemistry, vol. 267 (2000), pp. 5983-5994.
Proctor, George R., et al., “Azabenzocycloheptenones. Part 19. Formation of Some Heterocyclic Annelated Compounds from 1,2,3,4-Tetrahydro-1-benzazepine Derivatives,”Journal of the Chemical Society.Perkin Transactions I(1978) pp. 862-870.
International Search Report issued in PCT Application No. PCT/US2005/035458, which corresponds to U.S. Appl. No. 11/242,413.
Blackburn Christopher
Claiborne Christopher F.
Cullis Courtney A.
Dales Natalie A.
Patane Michael
Kifle Bruck
Millennium Pharmaceuticals Inc.
LandOfFree
Lactam compounds useful as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lactam compounds useful as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactam compounds useful as protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4044202